Soleimani, Ghazaleh
Nitsche, Michael A. https://orcid.org/0000-0002-2207-5965
Hanlon, Colleen A. https://orcid.org/0000-0002-3151-0279
Lim, Kelvin O. https://orcid.org/0000-0002-2390-7268
Opitz, Alexander
Ekhtiari, Hamed https://orcid.org/0000-0001-6902-8798
Funding for this research was provided by:
Minnesota's Discovery, Research and Innovation Economy
NARSAD young investigator award
Article History
Received: 22 October 2024
Revised: 10 March 2025
Accepted: 17 March 2025
First Online: 27 March 2025
Change Date: 19 May 2025
Change Type: Update
Change Details: The original online version of this article was revised: The copyright holder for this article was incorrectly given as ‘This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2025’ but should have been ‘The Author(s), under exclusive licence to American College of Neuropsychopharmacology 2025’.
Change Date: 18 June 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41386-025-02134-y
Competing interests
: MAN is in the scientific advisory boards of Neuroelectrics, and Precisis. CH is a member of BrainsWay’s senior leadership (Nov. 2022) and has a financial interest in BrainsWay. She has previously served on an advisory board for Welcony-Magstim and as a consultant for BrainsWay and Roswell Park Cancer Center. AO is an inventor on patents and patent applications describing methods and devices for non-invasive Brain Stimulation. Research reported in this publication was supported by the University of Minnesota’s MnDRIVE (Minnesota’s Discovery, Research and Innovation Economy) initiative awarded to GS and the University of Minnesota’s Medical Discovery Team on Addiction (MDTA). AO also acknowledges the support of the Minnesota Partnership for Biotechnology & Medical Genomics. The remaining authors have nothing to disclose